Paratome: an online tool for systematic identification of antigen-binding regions in antibodies based on sequence or structure
暂无分享,去创建一个
Yanay Ofran | Vered Kunik | Shaul Ashkenazi | Y. Ofran | Vered Kunik | Shaul Ashkenazi | Yanay Ofran
[1] P E Bourne,et al. Protein structure alignment by incremental combinatorial extension (CE) of the optimal path. , 1998, Protein engineering.
[2] David Schrama,et al. Antibody targeted drugs as cancer therapeutics , 2006, Nature Reviews Drug Discovery.
[3] A. Lesk,et al. Standard conformations for the canonical structures of immunoglobulins. , 1997, Journal of molecular biology.
[4] Chantal Abergel,et al. Identification of specificity‐determining residues in antibodies , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[5] H. Bilofsky,et al. Unusual distributions of amino acids in complementarity-determining (hypervariable) segments of heavy and light chains of immunoglobulins and their possible roles in specificity of antibody-combining sites. , 1977, The Journal of biological chemistry.
[6] E A Padlan. Structural implications of sequence variability in immunoglobulins. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[7] V. Giudicelli,et al. IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains. , 2003, Developmental and comparative immunology.
[8] C. Milstein,et al. Reshaping human antibodies: grafting an antilysozyme activity. , 1988, Science.
[9] M S Waterman,et al. Identification of common molecular subsequences. , 1981, Journal of molecular biology.
[10] B. Rost,et al. Analysing six types of protein-protein interfaces. , 2003, Journal of molecular biology.
[11] T. T. Wu,et al. AN ANALYSIS OF THE SEQUENCES OF THE VARIABLE REGIONS OF BENCE JONES PROTEINS AND MYELOMA LIGHT CHAINS AND THEIR IMPLICATIONS FOR ANTIBODY COMPLEMENTARITY , 1970, The Journal of experimental medicine.
[12] G. Winter,et al. Selection of phage antibodies by binding affinity. Mimicking affinity maturation. , 1992, Journal of molecular biology.
[13] Andrew C. Chan,et al. Therapeutic antibodies for autoimmunity and inflammation , 2010, Nature Reviews Immunology.
[14] Yanay Ofran,et al. Structural Consensus among Antibodies Defines the Antigen Binding Site , 2012, PLoS Comput. Biol..
[15] P. T. Jones,et al. Replacing the complementarity-determining regions in a human antibody with those from a mouse , 1986, Nature.
[16] Andrew J. Martin,et al. Antibody-antigen interactions: contact analysis and binding site topography. , 1996, Journal of molecular biology.
[17] B. Rost,et al. Automated Identification of Complementarity Determining Regions (CDRs) Reveals Peculiar Characteristics of CDRs and B Cell Epitopes1 , 2008, The Journal of Immunology.
[18] E. Kabat,et al. Sequences of proteins of immunological interest , 1991 .
[19] A. Lesk,et al. Conformations of immunoglobulin hypervariable regions , 1989, Nature.
[20] J. C. Almagro,et al. Identification of differences in the specificity‐determining residues of antibodies that recognize antigens of different size: implications for the rational design of antibody repertoires , 2004, Journal of molecular recognition : JMR.
[21] Ulrik B. Nielsen,et al. Affinity Maturation by Chain Shuffling and Site Directed Mutagenesis , 2001 .
[22] A. Lesk,et al. Canonical structures for the hypervariable regions of immunoglobulins. , 1987, Journal of molecular biology.